Topics in the latest “Pinkcast” include Keytruda’s approval and a look ahead to related PD-1 data anticipated at ESMO, plus how Pfizer is incorporating pharmacoeconomic data earlier in product development.
For a free trial of "The Pink Sheet", click here: http://www.pharmamedtechbi.com/publications/the-pink-sheet/free-trial?elsca1=pink&elsca2=pinkcast&utm_source=soundcloud&utm_medium=pinkcast
